MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innovent Biologics Inc (OP:IVBXF)

10.09 -0.15 (-1.43%)
Streaming Delayed Price Updated: 12:42 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Innovent Biologics Inc

< Previous 1 2 Next >
News headline image
FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab ↗
The FDA advisory committee voted against the full approval of Eli Lilly And Co's (NYSE: LLY) lung cancer treatment over concerns that the clinical trial was... 
Via Benzinga
News headline image
Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate ↗
Privately-held UNION therapeutics A/S and Innovent Biologics Inc's (OTC: IVBIY) subsidiary have entered into a strategic collaboration and license... 
Via Benzinga
News headline image
Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates ↗
Innovent Biologics Inc (OTC: IVBIY) and Bolt Biotherapeutics Inc (NASDAQ: BOLT) have entered into a drug research and development collaboration for oncology candidates. The... 
Via Benzinga
News headline image
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer ↗
Innovent Biologics Inc (OTC: IVBIY) has announced topline results from Phase 3 ORIENT-16 study evaluating sintilimab, meeting the primary endpoint of overall... 
Via Benzinga
News headline image
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients ↗
Innovent Biologics Inc (OTC: IVBIY) and Eli Lilly And Co (NYSE: LLY) have announced new and updated data from the ORIENT-11 Phase 3 study of sintilimab... 
Via Benzinga
News headline image
Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer ↗
The National Medical Products Administration (NMPA) of China has accepted for review Innovent Biologics Inc's (OTC: IVBIY) marketing application seeking... 
Via Benzinga
News headline image
Eli Lilly-Innovent Biologics Score Expanded Use Approval of Tyvyt n Lung Cancer Patients In China ↗
The National Medical Products Administration (NMPA) of China has approved Innovent Biologics Inc (OTC: IVBXF) and Eli Lilly And Co's (NYSE: LLY)... 
Via Benzinga
News headline image
Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA ↗
The FDA has accepted to review Innovent Biologics Inc (OTC: IVBIY) and Eli Lilly and Co's (NYSE: LLY) marketing application for sintilimab injection... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story